Microencapsulation by solvent evaporation: state of the art for process engineering approaches

International Journal of Pharmaceutics
Ming LiDenis Poncelet

Abstract

Microencapsulation by solvent evaporation technique is widely used in pharmaceutical industries. It facilitates a controlled release of a drug, which has many clinical benefits. Water insoluble polymers are used as encapsulation matrix using this technique. Biodegradable polymer PLGA (poly(lactic-co-glycolic acid)) is frequently used as encapsulation material. Different kinds of drugs have been successfully encapsulation: for example hydrophobic drugs such as cisplatin, lidocaine, naltrexone and progesterone; and hydrophilic drugs such as insulin, proteins, peptide and vaccine. The choice of encapsulation materials and the testing of the release of drug have been intensively investigated. However process-engineering aspects of this technique remain poorly reported. To succeed in the controlled manufacturing of microspheres, it is important to investigate the latter. This article reviews the current state of the art concerning this technique by focusing on the influence of the physical properties of materials and operating conditions on the microspheres obtained. Based on the existing results and authors' reflection, it gives rise to reasoning and suggested choices of materials and process conditions. A part of this paper is als...Continue Reading

References

Jul 1, 1987·International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine·M FatomeV Roman
Aug 1, 1986·Journal of Pharmaceutical Sciences·G SpenlehauerJ P Benoît
Feb 1, 1995·The Journal of Pharmacy and Pharmacology·M Boisdron-CelleJ P Benoit
Jan 1, 1996·Journal of Microencapsulation·Y F Maa, C Hsu
Mar 1, 1997·Journal of Microencapsulation·R JeyanthiP P DeLuca
Aug 1, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·C Witschi, E Doelker
Aug 5, 1998·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·J Herrmann, R Bodmeier
Feb 18, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·N B ViswanathanR A Mashelkar
Jun 17, 1999·International Journal of Pharmaceutics·P BouillotE Dellacherie
Oct 9, 1999·Journal of Pharmaceutical Sciences·Y N Sun, W J Jusko
Feb 17, 2000·International Journal of Pharmaceutics·H Sah
Jun 6, 2000·Advanced Drug Delivery Reviews·J W McGinity, P B O'Donnell
Jul 8, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·X LiZ Huang
Feb 13, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·M SinghD O'Hagan
Aug 8, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·T YamadaY Machida
Aug 23, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·M Diwan, T G Park
Jan 29, 2002·Journal of Microencapsulation·T MateovicA Mrhar
Nov 7, 2002·Biological & Pharmaceutical Bulletin·Junko TakishimaYoshiharu Machida
Sep 1, 2004·International Journal of Pharmaceutics·S Freiberg, X X Zhu
Sep 24, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Carlos ElviraConcepción Domingo
Mar 2, 2005·Colloids and Surfaces. B, Biointerfaces·Chuanyun DaiHongwei Zhao
Mar 7, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Li FengTsuneji Nagai
May 10, 2006·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Stacia FurtadoEdith Mathiowitz
Jul 19, 2006·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Ana F AzevedoAntónio J Almeida
Sep 19, 2006·Journal of Microencapsulation·Nader S BerchaneMalcolm J Andrews
Mar 21, 2007·International Journal of Pharmaceutics·Zohra ManaAlf Lamprecht

❮ Previous
Next ❯

Citations

Jul 24, 2010·Pharmaceutical Research·Hagar Ibrahim Labouta, Labiba K El-Khordagui
Dec 18, 2013·Archives of Pharmacal Research·Ki Hyun KimSeong Hoon Jeong
Jan 18, 2014·Materials Science & Engineering. C, Materials for Biological Applications·Rameshwar K Deshmukh, Jitendra B Naik
Dec 8, 2011·Chemistry Central Journal·Michal Pellach, Shlomo Margel
Oct 5, 2013·International Journal of Nanomedicine·Danay DupeyrónJosé Carlos T Carvalho
Feb 20, 2014·International Journal of Nanomedicine·Shih-shiung HuangMing-kung Yeh
Aug 21, 2013·Advanced Drug Delivery Reviews·A M Gañán-CalvoM Flores-Mosquera
Mar 25, 2014·Materials Science & Engineering. C, Materials for Biological Applications·Aline de Arce VelasquezLetícia Cruz
Sep 1, 2014·International Journal of Pharmaceutics·Rajendar R MallepallyKevin R Ward
Aug 12, 2014·International Journal of Pharmaceutics·M O BesenhardJ G Khinast
Nov 28, 2015·Journal of Microencapsulation·Francisca Casanova, Lúcia Santos
Jan 19, 2012·Expert Opinion on Drug Delivery·Ana Catarina LimaJoão F Mano
Jul 19, 2013·Drug Development and Industrial Pharmacy·Mônica Villa NovaMarcos Luciano Bruschi
May 26, 2015·Expert Opinion on Drug Delivery·Solmaz Maleki DizajFarzaneh Lotfipour
Sep 12, 2015·Drug Development and Industrial Pharmacy·Jessica BileYves Chevalier
Jul 28, 2012·Expert Opinion on Drug Delivery·Shirui MaoLuk Chiu Li
Aug 1, 2009·Journal of Pharmaceutical Sciences·Hagar I LaboutaGhaly M Ghaly
Sep 23, 2014·Journal of Pharmaceutical Sciences·Jan Kendall De KruifMartin Kuentz
Sep 26, 2009·Journal of Pharmaceutical Sciences·G Della PortaE Reverchon
Oct 21, 2015·Journal of Biomedical Materials Research. Part a·Qian HuWei Xue
Dec 17, 2014·Pharmaceutical Development and Technology·Jakub VysloužilKateřina Dvořáčková
Aug 21, 2012·International Journal of Pharmaceutics·Amélie GaignauxKarim Amighi
May 16, 2012·International Journal of Pharmaceutics·Xiujuan LiZhenping Wei
Jun 28, 2011·International Journal of Pharmaceutics·Mutukumaraswamy ShaillenderBjörn Neu
Jan 25, 2011·International Journal of Pharmaceutics·Van-Thanh TranMarie-Claire Venier-Julienne
Dec 17, 2014·Carbohydrate Polymers·Joice Aline Pires VilelaRosiane Lopes da Cunha
Sep 1, 2009·International Journal of Pharmaceutics·Hye-Yeum Im, Hongkee Sah
Nov 3, 2015·International Journal of Pharmaceutics·Muhammad IqbalAbdelhamid Elaissari
Apr 24, 2015·Dental Materials Journal·Hyun-Sun JeonBaek-Il Kim
Dec 1, 2015·Pharmaceutical Development and Technology·Kıvılcım ÖztürkSema Çalış
Oct 2, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jie ShenDiane J Burgess
Oct 23, 2010·Biotechnology and Bioengineering·G Della PortaE Reverchon
Jun 19, 2010·International Journal of Cosmetic Science·H-J KimH-H Jeong

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Controlled Release : Official Journal of the Controlled Release Society
Sergio FreitasBruno Gander
International Journal of Pharmaceutics
S Freiberg, X X Zhu
Advanced Drug Delivery Reviews
J W McGinity, P B O'Donnell
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V
Shirui MaoThomas Kissel
© 2022 Meta ULC. All rights reserved